Pharmaceutical Sales via Direct Marketing to Reach $10.6B in 2008

April 24, 2008

This article is included in these additional categories:

Free-Standing Inserts & Circulars | Pharma & Healthcare

Pharmaceutical companies are forecast to generate $10.6 billion in sales via direct marketing in 2008 – and $15.2 billion in 2012, according to a new Direct Marketing Association (DMA) report, “Direct Marketing Facts and Figures in the Pharmaceutical Industry.”

Key findings from the report include the following:

  • In 2008, pharmaceutical direct marketers will spend more than $1 billion on direct marketing, reap revenues of $10.6 billion, and earn an advertising ROI of $10.27 on each $1 spent.
  • Between 2007 and 2012, direct marketing-driven sales are projected to grow at a 9.4% compound annual growth rate (CAGR).
  • The business-to-business category is responsible for nearly 65% of pharmaceutical direct mail advertising today.
  • Commercial email spending is projected to increase at 21.9% CAGR from 2007 to 2012.
  • In 2012, internet advertising expenditures will be nearly $173 million, up from an expected $93.6 million this year.
  • Direct marketing-driven Web-driven sales this year will total nearly $1.9 billion – and by 2012 they will double, reaching nearly $3.8 billion.
  • Print marketing will generate more than $2 billion in sales this year.
  • From 2007 to 2012, direct mail spending is forecast to grow at a 7.1% CAGR.
  • Insert media sales is expected to surpass $41 million in 2008.

About the report: The 127-page report consists of nine chapters – Pharmaceutical Overview; Catalogs; Commercial Email; Direct Mail; Insert Media; Internet Marketing; Print Media; Broadcast Media; and Telephone Marketing – and is broken down into three subsets of data: direct marketing spending, sales, and employment.


Explore More Articles.

Marketing Charts Logo

Stay on the cutting edge of marketing.

Sign up for our free newsletter.

You have Successfully Subscribed!

Pin It on Pinterest

Share This